novocure(NVCR) - 2025 Q4 - Earnings Call Transcript

NovoCure (NasdaqGS:NVCR) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsChristoph Brackmann - CFOEmily Bodnar - VP, Equity ResearchFrank Leonard - CEOIngrid Goldberg - Head of Investor RelationsWilliam F. Doyle - Executive ChairmanConference Call ParticipantsAlbert Augustinus - AnalystJason Bednar - Managing Director and Senior Research AnalystNone - AnalystNone - AnalystOperatorThank you for standing by. Welcome to the Novocure Fourth Quarter 2025 Earnings Call. At this time, all p ...